
aRCC: 1L Treatment Options and Patient Management
GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After Multiple Lines of Systemic Therapy
206 views
December 28, 2022
Comments 1
Login to view comments.
Click here to Login